Literature DB >> 30070383

Ductular Reaction in Liver Diseases: Pathological Mechanisms and Translational Significances.

Keisaku Sato1,2,3, Marco Marzioni4, Fanyin Meng1,3,5, Heather Francis1,2,3, Shannon Glaser1,2,3, Gianfranco Alpini1,2,3.   

Abstract

Ductular reaction (DR) is characterized by the proliferation of reactive bile ducts induced by liver injuries. DR is pathologically recognized as bile duct hyperplasia and is commonly observed in biliary disorders. It can also be identified in various liver disorders including nonalcoholic fatty liver disease. DR is associated with liver fibrosis and damage, and the extent of DR parallels to patient mortality. DR raises scientific interests because it is associated with transdifferentiation of liver cells and may play an important role in hepatic regeneration. The origin of active cells during DR can be cholangiocytes, hepatocytes, or hepatic progenitor cells, and associated signaling pathways could differ depending on the specific liver injury or animal models used in the study. Although further studies are needed to elucidate detailed mechanisms and the functional roles in liver diseases, DR can be a therapeutic target to inhibit liver fibrosis and to promote liver regeneration. This review summarizes previous studies of DR identified in patients and animal models as well as currently understood mechanisms of DR.
© 2018 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2018        PMID: 30070383      PMCID: PMC6324973          DOI: 10.1002/hep.30150

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  72 in total

1.  Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers.

Authors:  Tania A Roskams; Neil D Theise; Charles Balabaud; Govind Bhagat; Prithi S Bhathal; Paulette Bioulac-Sage; Elizabeth M Brunt; James M Crawford; Heather A Crosby; Valeer Desmet; Milton J Finegold; Stephen A Geller; Annette S H Gouw; Prodromos Hytiroglou; A S Knisely; Masamichi Kojiro; Jay H Lefkowitch; Yasuni Nakanuma; John K Olynyk; Young Nyun Park; Bernard Portmann; Romil Saxena; Peter J Scheuer; Alastair J Strain; Swan N Thung; Ian R Wanless; A Brian West
Journal:  Hepatology       Date:  2004-06       Impact factor: 17.425

2.  Bile ductular proliferation as a prognostic factor in biliary atresia: an immunohistochemical assessment.

Authors:  Y Kinugasa; Y Nakashima; S Matsuo; K Shono; S Suita; K Sueishi
Journal:  J Pediatr Surg       Date:  1999-11       Impact factor: 2.545

3.  Dynamics of the vascular profile of the finer branches of the biliary tree in normal and diseased human livers.

Authors:  Annette S H Gouw; Marius C van den Heuvel; Marcel Boot; Maarten J H Slooff; Sibrand Poppema; Koert P de Jong
Journal:  J Hepatol       Date:  2006-05-02       Impact factor: 25.083

4.  Identification of hepatocytic and bile ductular cell lineages and candidate stem cells in bipolar ductular reactions in cirrhotic human liver.

Authors:  Hongchao Zhou; Leslie E Rogler; Lewis Teperman; Glyn Morgan; Charles E Rogler
Journal:  Hepatology       Date:  2007-03       Impact factor: 17.425

5.  Oval cells in hepatitis B virus-positive and hepatitis C virus-positive liver cirrhosis: histological and ultrastructural study.

Authors:  C Sun; X-L Jin; J-C Xiao
Journal:  Histopathology       Date:  2006-04       Impact factor: 5.087

6.  Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules.

Authors:  Young Nyun Park; Masamichi Kojiro; Luca Di Tommaso; Amar P Dhillon; Fukuo Kondo; Masayuki Nakano; Michiie Sakamoto; Neil D Theise; Massimo Roncalli
Journal:  Cancer       Date:  2007-03-01       Impact factor: 6.860

7.  Transdifferentiation of rat hepatocytes into biliary cells after bile duct ligation and toxic biliary injury.

Authors:  George K Michalopoulos; Lindsay Barua; William C Bowen
Journal:  Hepatology       Date:  2005-03       Impact factor: 17.425

8.  Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis.

Authors:  Andrew D Clouston; Elizabeth E Powell; Meagan J Walsh; Michelle M Richardson; A Jake Demetris; Julie R Jonsson
Journal:  Hepatology       Date:  2005-04       Impact factor: 17.425

9.  An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response.

Authors:  M G Chiaramonte; D D Donaldson; A W Cheever; T A Wynn
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

10.  Hepatocytes undergo phenotypic transformation to biliary epithelium in organoid cultures.

Authors:  George K Michalopoulos; William C Bowen; Karen Mulè; Juan Carlos Lopez-Talavera; Wendy Mars
Journal:  Hepatology       Date:  2002-08       Impact factor: 17.425

View more
  92 in total

1.  Activated cholangiocytes release macrophage-polarizing extracellular vesicles bearing the DAMP S100A11.

Authors:  Tomohiro Katsumi; Maria Eugenia Guicciardi; Adiba Azad; Steven F Bronk; Anuradha Krishnan; Gregory J Gores
Journal:  Am J Physiol Cell Physiol       Date:  2019-07-31       Impact factor: 4.249

2.  Modulation of the Tryptophan Hydroxylase 1/Monoamine Oxidase-A/5-Hydroxytryptamine/5-Hydroxytryptamine Receptor 2A/2B/2C Axis Regulates Biliary Proliferation and Liver Fibrosis During Cholestasis.

Authors:  Konstantina Kyritsi; Lixian Chen; April O'Brien; Heather Francis; Travis W Hein; Julie Venter; Nan Wu; Ludovica Ceci; Tianhao Zhou; David Zawieja; Anatoliy A Gashev; Fanyin Meng; Pietro Invernizzi; Luca Fabris; Chaodong Wu; Nicholas J Skill; Romil Saxena; Suthat Liangpunsakul; Gianfranco Alpini; Shannon S Glaser
Journal:  Hepatology       Date:  2019-10-18       Impact factor: 17.425

Review 3.  Emerging Players in Autophagy Deficiency-Induced Liver Injury and Tumorigenesis.

Authors:  Hua Yang; Hong-Min Ni; Wen-Xing Ding
Journal:  Gene Expr       Date:  2019-01-28

Review 4.  CGI-58: Versatile Regulator of Intracellular Lipid Droplet Homeostasis.

Authors:  Liqing Yu; Yi Li; Alison Grisé; Huan Wang
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

5.  The Therapeutic Potential of Extracellular Vesicles Versus Mesenchymal Stem Cells in Liver Damage.

Authors:  Dina M Rostom; Noha Attia; Hoda M Khalifa; Maha W Abou Nazel; Eshrak A El Sabaawy
Journal:  Tissue Eng Regen Med       Date:  2020-06-06       Impact factor: 4.169

6.  Inside-Out or Outside-In: Choosing the Right Model of Hepatocellular Cancer.

Authors:  Satdarshan P Monga
Journal:  Gene Expr       Date:  2020-06-05

Review 7.  Cholangiocarcinoma: novel therapeutic targets.

Authors:  Keisaku Sato; Shannon Glaser; Domenico Alvaro; Fanyin Meng; Heather Francis; Gianfranco Alpini
Journal:  Expert Opin Ther Targets       Date:  2020-02-26       Impact factor: 6.902

Review 8.  Liver Progenitors and Adult Cell Plasticity in Hepatic Injury and Repair: Knowns and Unknowns.

Authors:  Sungjin Ko; Jacquelyn O Russell; Laura M Molina; Satdarshan P Monga
Journal:  Annu Rev Pathol       Date:  2019-08-09       Impact factor: 23.472

9.  Hedgehog Signaling Demarcates a Niche of Fibrogenic Peribiliary Mesenchymal Cells.

Authors:  Vikas Gupta; Ishaan Gupta; Jiwoon Park; Yaron Bram; Robert E Schwartz
Journal:  Gastroenterology       Date:  2020-04-11       Impact factor: 22.682

10.  Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor Deficiency Promotes the Ductular Reaction, Macrophage Accumulation, and Hepatic Fibrosis in the Abcb4-/- Mouse.

Authors:  Anuradha Krishnan; Tomohiro Katsumi; Maria E Guicciardi; Adiba I Azad; Nazli B Ozturk; Christy E Trussoni; Gregory J Gores
Journal:  Am J Pathol       Date:  2020-03-30       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.